Stollar B D, De Clercq E, Drocourt J L, Thang M N
Eur J Biochem. 1978 Jan 16;82(2):339-46. doi: 10.1111/j.1432-1033.1978.tb12028.x.
Several pure poly(I) preparations differed in: (a) their complement fixation reactivity with anti-poly(I) antiserum; (b) their ability to bind to a solid-phase anti-poly(I) antibody-Sepharose column; (c) their ability to inactivate serum complement; and (d) their reactivity with purified antibodies to double-stranded RNA. In particular, poly(I) samples that could induce interferon production differed from non-inducer poly(I)s; the inducers reacted weakly with anti-poly(I) antiserum and were the only ones that reacted with antibodies to double-stranded RNA. One inducer poly(I) did not inactivate complement, and differed from non-inducer poly(I) in quantitative aspects of poly(I) . poly(C) formation with varying amounts of poly(C). An additional type of poly(I) preparation reacted poorly with anti-poly(I) antiserum, did not react with anti-double-stranded-RNA antibodies and failed to induce interferon production. The varying forms of poly(I) were not interconvertible by boiling and rapid chilling. These results indicate that several different stable structural forms of poly(I) may result from a standardized synthetic procedure.
几种纯聚肌苷(poly(I))制剂在以下方面存在差异:(a)它们与抗聚肌苷抗血清的补体结合反应性;(b)它们与固相抗聚肌苷抗体 - 琼脂糖柱结合的能力;(c)它们使血清补体失活的能力;以及(d)它们与双链RNA纯化抗体的反应性。特别地,能够诱导干扰素产生的聚肌苷样品与非诱导性聚肌苷不同;诱导剂与抗聚肌苷抗血清反应较弱,并且是唯一与双链RNA抗体反应的聚肌苷。一种诱导性聚肌苷不能使补体失活,并且在聚肌苷与不同量聚胞苷酸(poly(C))形成聚肌苷 - 聚胞苷酸(poly(I)·poly(C))的定量方面与非诱导性聚肌苷不同。另一种聚肌苷制剂与抗聚肌苷抗血清反应较差,不与抗双链RNA抗体反应,并且不能诱导干扰素产生。聚肌苷的不同形式不能通过煮沸和快速冷却相互转化。这些结果表明,标准化的合成程序可能会产生几种不同的稳定结构形式的聚肌苷。